|
1
|
Janda M, Gebski V, Davies LC, Forder P,
Brand A, Hogg R, Jobling TW, Land R, Manolitsas T, Nascimento M, et
al: Effect of total laparoscopic hysterectomy vs total abdominal
hysterectomy on disease-free survival among women with stage I
endometrial cancer: A randomized clinical trial. JAMA.
317:1224–1233. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Amant F, Moerman P, Neven P, Timmerman D,
Van Limbergen E and Vergote I: Endometrial cancer. Lancet.
366:491–505. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kamachi Y and Kondoh H: Sox proteins:
Regulators of cell fate specification and differentiation.
Development. 140:4129–4144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The microRNA. org resource: Targets and expression.
Nucleic Acids Res. 36:D149–D153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ye YW, Wu JH, Wang CM, Zhou Y, Du CY,
Zheng BQ, Cao X, Zhou XY, Sun MH and Shi YQ: Sox17 regulates
proliferation and cell cycle during gastric cancer progression.
Cancer Lett. 307:124–131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yin D, Jia Y, Yu Y, Brock MV, Herman JG,
Han C, Su X, Liu Y and Guo M: SOX17 methylation inhibits its
antagonism of Wnt signaling pathway in lung cancer. Discov Med.
14:33–40. 2012.PubMed/NCBI
|
|
7
|
Jia Y, Yang Y, Zhan Q, Brock MV, Zheng X,
Yu Y, Herman JG and Guo M: Inhibition of SOX17 by microRNA 141 and
methylation activates the WNT signaling pathway in esophageal
cancer. J Mol Diagn. 14:577–585. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Bao W, Wang K, Lu W, Wang H, Tong
H and Wan X: SOX17 is a tumor suppressor in endometrial cancer.
Oncotarget. 7:76036–76046. 2016.PubMed/NCBI
|
|
9
|
Kuo I, Wu CC, Chang JM, Huang YL, Lin CH,
Yan JJ, Sheu BS, Lu PJ, Chang WL, Lai WW and Wang YC: Low SOX17
expression is a prognostic factor and drives transcriptional
dysregulation and esophageal cancer progression. Int J Cancer.
135:563–573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Jiang F, Bao W, Zhang H, He X,
Wang H and Wan X: SOX17 increases the cisplatin sensitivity of an
endometrial cancer cell line. Cancer Cell Int. 16:292016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vonlanthen S, Heighway J, Altermatt H,
Gugger M, Kappeler A, Borner MM, van Lohuizen M and Betticher DC:
The bmi-1 oncoprotein is differentially expressed in non-small cell
lung cancer and correlates with INK4A-ARF locus expression. Br J
Cancer. 84:1372–1376. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Browne G, Taipaleenmäki H, Stein GS, Stein
JL and Lian JB: MicroRNAs in the control of metastatic bone
disease. Trends Endocrinol Metab. 25:320–327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mei Z, Zhou L, Zhu Y, Jie K, Fan D, Chen
J, Liu X, Jiang L, Jia Q and Li W: Interleukin-22 promotes
papillary thyroid cancer cell migration and invasion through
microRNA-595/Sox17 axis. Tumour Biol. 37:11753–11762. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Myatt SS, Wang J, Monteiro LJ, Christian
M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S and Lam EW:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong P, Kaneuchi M, Watari H, Hamada J,
Sudo S, Ju J and Sakuragi N: MicroRNA-194 inhibits epithelial to
mesenchymal transition of endometrial cancer cells by targeting
oncogene BMI-1. Mol Cancer. 10:992011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qin X, Yan L, Zhao X, Li C and Fu Y:
MicroRNA-21 overexpression contributes to cell proliferation by
targeting PTEN in endometrioid endometrial cancer. Oncol Lett.
4:1290–1296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liao XH, Lu DL, Wang N, Liu LY, Wang Y, Li
YQ, Yan TB, Sun XG, Hu P and Zhang TC: Estrogen receptor α mediates
proliferation of breast cancer MCF-7 cells via a
p21/PCNA/E2F1-dependent pathway. FEBS J. 281:927–942. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang P, Zhang L, Zhang J and Xu G:
MicroRNA-124-3p inhibits cell growth and metastasis in cervical
cancer by targeting IGF2BP1. Exp Ther Med. 15:1385–1393.
2018.PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Junn E, Lee KW, Jeong BS, Chan TW, Im JY
and Mouradian MM: Repression of alpha-synuclein expression and
toxicity by microRNA-7. Proc Natl Acad Sci USA. 106:13052–13057.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang SY, Caamano J, Cooper F, Guo X and
Klein-Szanto AJ: Immunohistochemistry of cyclin D1 in human breast
cancer. Am J Clin Pathol. 102:695–698. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hauke J and Kossowski T: Comparison of
values of Pearson's and Spearman's correlation coefficients on the
same sets of data. Quaestiones Geographicae. 30:87–93. 2011.
View Article : Google Scholar
|
|
24
|
Metz CE: Basic principles of ROC analysis.
Semin Nucl Med. 8:283–298. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zweig MH and Campbell G:
Receiver-operating characteristic (ROC) plots: A fundamental
evaluation tool in clinical medicine. Clin Chem. 39:561–577. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao J, Niwa K, Sun W, Takemura M, Lian Z,
Onogi K, Seishima M, Mori H and Tamaya T: Non-steroidal
anti-inflammatory drugs inhibit cellular proliferation and
upregulate cyclooxygenase-2 protein expression in endometrial
cancer cells. Cancer Sci. 95:901–907. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsuji T, Ibaragi S and Hu GF:
Epithelial-mesenchymal transition and cell cooperativity in
metastasis. Cancer Res. 69:7135–7139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gavert N and Ben-Ze'ev A:
Epithelial-mesenchymal transition and the invasive potential of
tumors. Trends Mol Med. 14:199–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
